Contact Information
23 Aldrin Road , Plymouth, Massachusetts 2360, United States
Detailed Information
BrightView Health Plymouth
-
Services:
- This facility administers/prescribes medication for alcohol use disorder
- Private for-profit organization
- Opioids detoxification
- Methamphetamines detoxification
- Cocaine Detoxification
- Medication routinely used during detoxification
- Benzodiazepines Detoxification
- Alcohol Detoxification
- Intensive outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Outpatient day treatment or partial hospitalization
- Outpatient
- Outpatient detoxification
- Federal military insurance (e.g., TRICARE)
- Medicaid
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Cash or self-payment
- Medicare
- Screening for tobacco use
- Comprehensive substance use assessment
- Screening for substance use
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Group counseling
- Substance use disorder education
- Individual counseling
- Mentoring/peer support
- Assistance with obtaining social services
- Housing services
- Female
- Male
- Drug or alcohol urine screening
- Vaping permitted in designated area
- Contingency management/motivational incentives
- Relapse prevention
- Cognitive behavioral therapy
- Substance use disorder counseling
- Motivational interviewing
- Trauma-related counseling
- Brief intervention
- Community reinforcement plus vouchers
- Matrix Model
- Telemedicine/telehealth therapy
- In-network prescribing entity
- Detoxification
- Substance use treatment
- Young Adults
- Adults
- Prescribes buprenorphine
- Buprenorphine maintenance
- Prescribes naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Case management service
- Social skills development
- Smoking permitted in designated area
- The Joint Commission
- Sign language services for the deaf and hard of hearing
- In-network prescribing entity
- Pregnant/postpartum women
- Adult men
- Adult women
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Disulfiram
- Non-nicotine smoking/tobacco cessation
- Buprenorphine sub-dermal implant
- Naltrexone (oral)
- Acamprosate (CampralĀ®)
- Nicotine replacement
- Buprenorphine (extended-release, injectable)
- Naltrexone (extended-release, injectable)
- Outcome follow-up after discharge
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
Type of Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)
Detoxification (medical withdrawal) Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Payment/Insurance/Funding Accepted
Assessment/Pre-treatment
Opioid Medications used in Treatment
Education and Counseling Services
Recovery Support Services
Gender Accepted
Testing
Facility Vaping Policy
Treatment Approaches
External Opioid Medications Source
Type of Care
Age Groups Accepted
Type of Opioid Treatment
Ancillary Services
Facility Smoking Policy
License/Certification/Accreditation
Language Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Special Programs/Groups Offered
Pharmacotherapies
Transitional Services
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm